Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Human Erythropoietin Injection

Approval Number

国药准字S20050028

Company深圳未名新鹏生物医药有限公司

Registration Date

March 10, 2020

Drug Information

Generic Name

人促红素注射液

Dosage Form

注射剂

Strength

2000IU/1.0ml/支

Drug Type

生物制品

Registration Date

March 10, 2020

Company Information

Applicant Company

Company Name深圳未名新鹏生物医药有限公司

Manufacturing Company

Company Name深圳未名新鹏生物医药有限公司

Company Address

深圳市南山区西丽街道高新北二道18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

人促红素注射液 - NMPA 批准文号 | MedPath